Meridian Wealth Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Meridian Wealth Advisors's EW Position: Q4 2024 in Review
Meridian Wealth Advisors sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 9,033 shares — an estimated $596K sold.
Meridian Wealth Advisors first reported a position in EW in Q4 2020 and held it in 16 quarters. The position peaked at $2.96M in Q4 2021. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2024.
- Meridian Wealth Advisors reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
- Meridian Wealth Advisors sold 9,033 Edwards Lifesciences shares in Q4 2024, an estimated $596K.
- Meridian Wealth Advisors first reported a position in Edwards Lifesciences in Q4 2020 and held it in 16 quarters.
- Meridian Wealth Advisors's Edwards Lifesciences position peaked at $2.96M in Q4 2021.
- 1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.
Based on Meridian Wealth Advisors's 13F filing for Q4 2024, filed 11 Feb 2025.